RIGL
Rigel Pharmaceuticals Inc
Price:  
10.75 
USD
Volume:  
59,572.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL WACC - Weighted Average Cost of Capital

The WACC of Rigel Pharmaceuticals Inc (RIGL) is 7.3%.

The Cost of Equity of Rigel Pharmaceuticals Inc (RIGL) is 7.50%.
The Cost of Debt of Rigel Pharmaceuticals Inc (RIGL) is 9.40%.

Range Selected
Cost of equity 6.40% - 8.60% 7.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.80% 9.40%
WACC 6.1% - 8.6% 7.3%
WACC

RIGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.54 0.66
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 8.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.35 0.35
Cost of debt 7.00% 11.80%
After-tax WACC 6.1% 8.6%
Selected WACC 7.3%